tiprankstipranks
Trending News
More News >
TG Therapeutics (TGTX)
NASDAQ:TGTX
US Market

TG Therapeutics (TGTX) Ratios

Compare
2,111 Followers

TG Therapeutics Ratios

TGTX's free cash flow for Q3 2025 was $0.83. For the 2025 fiscal year, TGTX's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.82 6.25 5.92 3.16 5.06
Quick Ratio
2.89 5.03 5.18 3.16 5.42
Cash Ratio
0.47 1.98 1.73 1.92 4.57
Solvency Ratio
1.07 0.07 0.08 -1.51 -2.49
Operating Cash Flow Ratio
-0.45 -0.45 -0.58 -3.31 -4.52
Short-Term Operating Cash Flow Coverage
-85.04 0.00 0.00 -111.43 -122.57
Net Current Asset Value
$ 181.96M$ 211.03M$ 148.86M$ 33.29M$ 188.49M
Leverage Ratios
Debt-to-Assets Ratio
0.25 0.44 0.34 0.43 0.21
Debt-to-Equity Ratio
0.42 1.14 0.69 -0.05 -0.06
Debt-to-Capital Ratio
0.29 0.53 0.41 -0.06 -0.06
Long-Term Debt-to-Capital Ratio
0.29 0.52 0.38 -0.05 -0.05
Financial Leverage Ratio
1.69 2.60 2.05 -0.13 -0.29
Debt Service Coverage Ratio
16.92 1.98 2.04 -16.41 -43.41
Interest Coverage Ratio
3.77 1.75 1.64 -18.92 -61.15
Debt to Market Cap
0.05 0.06 0.04 0.05 0.03
Interest Debt Per Share
1.93 1.91 0.87 0.69 0.64
Net Debt to EBITDA
1.56 1.48 0.68 0.10 0.64
Profitability Margins
Gross Profit Margin
85.33%88.30%93.95%90.48%88.19%
EBIT Margin
21.62%15.08%10.99%-6755.62%-5119.79%
EBITDA Margin
21.67%15.17%11.17%-6737.13%-5112.41%
Operating Profit Margin
19.32%12.74%8.83%-6924.20%-5154.28%
Pretax Profit Margin
16.50%7.78%5.59%-7121.54%-5204.08%
Net Profit Margin
84.13%7.11%5.42%-7318.89%-5315.47%
Continuous Operations Profit Margin
84.13%7.11%5.42%-7121.54%-5204.08%
Net Income Per EBT
509.94%91.36%97.01%102.77%102.14%
EBT Per EBIT
85.38%61.04%63.31%102.85%100.97%
Return on Assets (ROA)
43.65%4.05%3.84%-105.30%-93.66%
Return on Equity (ROE)
133.25%10.52%7.90%13.35%26.76%
Return on Capital Employed (ROCE)
11.84%8.61%7.48%-137.38%-109.71%
Return on Invested Capital (ROIC)
11.81%7.85%7.22%-138.07%-110.71%
Return on Tangible Assets
43.65%4.05%3.85%-105.74%-93.86%
Earnings Yield
9.73%0.53%0.52%-12.72%-14.15%
Efficiency Ratios
Receivables Turnover
2.00 2.55 4.57 0.00 4.82
Payables Turnover
0.69 0.00 0.37 <0.01 0.00
Inventory Turnover
0.53 0.35 0.35 0.00 -0.03
Fixed Asset Turnover
81.82 46.01 28.69 0.26 0.60
Asset Turnover
0.52 0.57 0.71 0.01 0.02
Working Capital Turnover Ratio
1.14 0.89 1.23 0.01 0.02
Cash Conversion Cycle
344.03 1.19K 114.73 -57.88K -10.83K
Days of Sales Outstanding
182.11 143.32 79.81 0.00 75.79
Days of Inventory Outstanding
687.37 1.05K 1.03K 0.00 -10.91K
Days of Payables Outstanding
525.45 0.00 993.70 57.88K 0.00
Operating Cycle
869.49 1.19K 1.11K 0.00 -10.83K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.48 -0.28 -0.22 -1.30 -2.24
Free Cash Flow Per Share
-0.48 -0.28 -0.22 -1.30 -2.24
CapEx Per Share
<0.01 <0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-417.10 -900.38 0.00 -12.58K -737.24
Capital Expenditure Coverage Ratio
-417.10 -900.38 0.00 -12.58K -737.24
Operating Cash Flow Coverage Ratio
-0.28 -0.16 -0.28 -2.12 -3.74
Operating Cash Flow to Sales Ratio
-0.13 -0.12 -0.13 -63.26 -44.20
Free Cash Flow Yield
-1.40%-0.93%-1.30%-11.00%-11.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.28 187.06 191.33 -7.86 -7.07
Price-to-Sales (P/S) Ratio
9.44 13.29 10.38 575.19 375.58
Price-to-Book (P/B) Ratio
7.57 19.67 15.11 -1.05 -1.89
Price-to-Free Cash Flow (P/FCF) Ratio
-71.49 -107.84 -77.18 -9.09 -8.49
Price-to-Operating Cash Flow Ratio
-65.64 -107.96 -77.18 -9.09 -8.50
Price-to-Earnings Growth (PEG) Ratio
0.02 2.36 -1.81 0.18 -0.83
Price-to-Fair Value
7.57 19.67 15.11 -1.05 -1.89
Enterprise Value Multiple
45.13 89.13 93.58 -8.44 -6.70
Enterprise Value
5.20B 4.45B 2.44B 1.58B 2.29B
EV to EBITDA
45.13 89.13 93.58 -8.44 -6.70
EV to Sales
9.78 13.52 10.45 568.28 342.71
EV to Free Cash Flow
-74.05 -109.66 -77.75 -8.98 -7.74
EV to Operating Cash Flow
-74.23 -109.78 -77.75 -8.98 -7.75
Tangible Book Value Per Share
4.18 1.53 1.13 0.43 1.79
Shareholders’ Equity Per Share
4.18 1.53 1.13 -11.28 -10.05
Tax and Other Ratios
Effective Tax Rate
-4.10 0.09 0.03 -0.03 -0.02
Revenue Per Share
3.66 2.26 1.65 0.02 0.05
Net Income Per Share
3.08 0.16 0.09 -1.51 -2.69
Tax Burden
5.10 0.91 0.97 1.03 1.02
Interest Burden
0.76 0.52 0.51 1.05 1.02
Research & Development to Revenue
0.27 0.29 0.33 40.26 29.68
SG&A to Revenue
0.39 0.47 0.53 29.89 22.74
Stock-Based Compensation to Revenue
0.11 0.13 0.16 6.89 9.16
Income Quality
-0.16 -1.73 -2.48 0.89 0.85
Currency in USD